Caloric Restriction

3

Review clinical trials related to Caloric Restriction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes

To evaluate the effects of subcutaneous injection of semaglutide for 12 weeks on patients with type 2 diabetes mellitus (T2DM), compared with concurrent energy-restricted management, on glycemic control, weight loss, inflammatory markers, liver fat content, and other parameters. The study also observed the subcutaneous and visceral fat of the participants and explored the molecular mechanisms of action, providing high-quality evidence-based support for the timing and targets of intervention in this population.

Participants needed: 100
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital of Nanchang UniversityUpdated: Apr 2, 2026Locations: 1
Eligibility criteria

Age 18-75 years; [+5]

BMI < 25 kg/m²; [+8]

Status: Recruiting

BRAHMS: Bed Rest And HypoMetabolism Study

The goal of this single arm, interventional monocentric clinical trial is to investigate the physiological effects of a combination of head-down bedrest and caloric restriction on the human body. A set of measurements will assess the changes in the musculoskeletal, cardiovascular, hematological, immune, neurological, cognitive and metabolic systems, in 10 healthy male volunteers. The main question it aims to answer is: what are the physiological responses to fasting in a microgravity environment? In an exploratory study such as this one, where many physiological systems are explored, it is difficult to select a single important endpoint. However, given the known effect of both caloric restriction and head-down bedrest on muscle loss, and its critical importance for the success of space missions, lean body mass, as assessed by DEXA, was chosen as the primary endpoint. The secondary endpoints are: * Cardiovascular, muscular, neuro-vestibular and neuropsychological functional performance * The onset of clinical symptoms and biological changes Participants will be exposed to a microgravity analog model (head down bed rest) and controled caloric restriction environment for 10 days, multiple physiological assessments will be performed during this period. Followed by a rehab period before leaving the study.

Participants needed: 10
Trial details
Age: 20-40Biological sex: MaleType: InterventionalSponsor: Centre National d'Etudes SpatialesUpdated: Mar 30, 2026Locations: 1
Eligibility criteria

Healthy male volunteers (see below the description of medical tests and laborato... [+14]

Symptomatic orthostatic hypotension whatever the decrease in blood pressure, or... [+38]

Status: Not yet recruiting

The Effect of Time Restricted Eating on Glycemic and Proinflammatory Biomarkers Among Prediabetic Obese Jordanian Adults Aged 18-40 Years Old

Obesity, a global epidemic, significantly contributes to prediabetes, cardiovascular diseases, and other chronic diseases due to its pro-inflammatory nature. This studyl investigates the effects of time-restricted eating (TRE) with calorie restriction (CR), TRE without CR, and CR without TRE on glycemic control and pro-inflammatory biomarkers among prediabetic obese Jordanian adults aged 18-40 years. The study assesses changes in pro-inflammatory biomarkers (IL-1β, TNF-α, IL-6), insulin resistance (HOMA-IR), and body composition over 12 weeks. Participants (n=120) will be randomized into four intervention arms: (1) TRE with CR, (2) TRE without CR, (3) CR without TRE, and (4) a control group with no dietary restrictions and no TRE. Biweekly anthropometric assessments will evaluate pro-inflammatory biomarkers and biochemical measures at baseline and the end of the study. The findings will provide insights into the comparative effectiveness of TRE and CR, potentially offering a safe, cost-effective intervention to prevent obesity-induced inflammation, prediabetes, and progression to type 2 diabetes mellitus.

Participants needed: 120
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: University of JordanUpdated: Apr 4, 2025Locations: 1
Eligibility criteria

IR individuals diagnosed with IR by the physicians as indicated by HOMA-IR score [+4]

previous weight loss surgery [+6]